• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A role for defibrillation threshold testing? A case of ventricular fibrillation refractory to implantable cardioverter-defibrillator shocks in setting of cardiac amyloidosis.

作者信息

Lee Tyler, Marinchak Roger

机构信息

Jefferson Abington Hospital, Abington, Pennsylvania.

出版信息

HeartRhythm Case Rep. 2025 Mar 3;11(5):492-495. doi: 10.1016/j.hrcr.2025.02.020. eCollection 2025 May.

DOI:10.1016/j.hrcr.2025.02.020
PMID:40656007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12242980/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/1eae220aea7f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/33aa4d9a4721/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/feb25cccaa73/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/b6003c8d0bd7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/1eae220aea7f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/33aa4d9a4721/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/feb25cccaa73/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/b6003c8d0bd7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab58/12242980/1eae220aea7f/gr4.jpg

相似文献

1
A role for defibrillation threshold testing? A case of ventricular fibrillation refractory to implantable cardioverter-defibrillator shocks in setting of cardiac amyloidosis.除颤阈值测试有作用吗？一例心脏淀粉样变性患者发生对植入式心脏复律除颤器电击耐受的心室颤动
HeartRhythm Case Rep. 2025 Mar 3;11(5):492-495. doi: 10.1016/j.hrcr.2025.02.020. eCollection 2025 May.
2
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试：多中心ASSURE研究（心律失常单次电击除颤阈值测试与易损性上限：植入式心脏复律除颤器植入的风险降低评估）结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
3
Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.易损性上限是经静脉植入式心脏复律除颤器的人类患者中与90%成功除颤概率相关的电击强度的良好估计指标。
J Am Coll Cardiol. 1996 Apr;27(5):1112-8. doi: 10.1016/0735-1097(95)00603-6.
4
Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.使用带有三电极系统的植入式心脏复律除颤器进行心内膜除颤的初步临床经验。
Arch Intern Med. 1989 Oct;149(10):2333-9.
5
Catheter Ablation of Ventricular Arrhythmia in Patients With an Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-analysis.植入式心脏复律除颤器患者室性心律失常的导管消融：一项系统评价和荟萃分析。
Can J Cardiol. 2023 Mar;39(3):250-262. doi: 10.1016/j.cjca.2022.12.004. Epub 2022 Dec 12.
6
Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold.对于皮下植入式心律转复除颤器患者，将电极从左侧重新放置到胸骨右缘对显示高除颤阈值的有效性。
J Arrhythm. 2018 Dec 7;35(1):133-135. doi: 10.1002/joa3.12145. eCollection 2019 Feb.
7
Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery.三尖瓣手术后心尖静脉内置入式心脏除颤器导线的放置。
Europace. 2012 Jun;14(6):853-8. doi: 10.1093/europace/eus013. Epub 2012 Feb 14.
8
STEPWISE CARDIAC REHABILITATION ADJUSTMENT AFTER EXERCISE-INDUCED IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCK: A CASE REPORT.运动诱发植入式心脏复律除颤器电击后逐步进行心脏康复调整：一例报告
J Rehabil Med Clin Commun. 2025 Apr 16;8:42483. doi: 10.2340/jrm-cc.v8.42483. eCollection 2025.
9
Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.可植入式心律转复除颤器对遗传性心律失常综合征年轻患者的危害：不适当电击和并发症的系统评价和荟萃分析。
Heart Rhythm. 2016 Feb;13(2):443-54. doi: 10.1016/j.hrthm.2015.09.010. Epub 2015 Sep 15.
10
Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.体重指数对皮下植入式心脏除颤器的安全性和疗效的影响。
JACC Clin Electrophysiol. 2018 May;4(5):652-659. doi: 10.1016/j.jacep.2017.11.019. Epub 2018 Feb 2.

本文引用的文献

1
Infiltration of Conduction Tissue Is a Major Cause of Electrical Instability in Cardiac Amyloidosis.传导组织浸润是心脏淀粉样变性电不稳定的主要原因。
J Clin Med. 2023 Feb 23;12(5):1798. doi: 10.3390/jcm12051798.
2
A case of AL amyloidosis presenting with refractory ventricular fibrillation.一例以难治性心室颤动为表现的AL型淀粉样变性病例。
Respir Med Case Rep. 2021 Jan 24;32:101349. doi: 10.1016/j.rmcr.2021.101349. eCollection 2021.
3
Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.心脏淀粉样变性患者与植入式心脏复律除颤器的治疗结果
Europace. 2020 Aug 1;22(8):1216-1223. doi: 10.1093/europace/euaa094.
4
Coronary vein defibrillator coil placement in patients with high defibrillation thresholds.高除颤阈值患者冠状动脉静脉除颤器线圈的放置
J Arrhythm. 2018 Dec 3;35(1):79-85. doi: 10.1002/joa3.12136. eCollection 2019 Feb.
5
Defibrillation Threshold Testing: Current Status.除颤阈值测试：现状
Arrhythm Electrophysiol Rev. 2018 Dec;7(4):288-293. doi: 10.15420/aer.2018.54.2.
6
Azygos vein lead implantation for high defibrillation thresholds in implantable cardioverter defibrillator placement.在植入式心脏复律除颤器放置中，奇静脉导联植入用于高除颤阈值情况。
Indian Pacing Electrophysiol J. 2010 Jan 7;10(1):49-54.
7
Cardiac amyloidosis treated with an implantable cardioverter defibrillator and subcutaneous array lead system: report of a case and literature review.植入式心脏复律除颤器和皮下阵列导线系统治疗心脏淀粉样变性：一例报告及文献综述
Clin Cardiol. 2009 Aug;32(8):E63-5. doi: 10.1002/clc.20389.